Pew Survey/Research Center, 98,
198-199
Pharmaceuticals, 144, 152 Populations, 5, 10,42-43, 72 aging population, 102, 204 See also under Urban centers Ports, 9,10
Postal Saving Bank, 172 Poverty, 199
Prices, 8,12, 31, 32, 35, 54, 57, 60, 69, 80, 83,130,168,180,212 competition on, 212-213 state-set vs. market-based, 99 transfer pricing, 109,178,206 See also Costs Privatization, 37, 61, 99 Procter & Gamble (P&G), 46,49-50, 52, 118,152, 154,177 Product development, 58,151, 182 Production networks, 75 Productive capacity, 71 Productivity, 6,11, 200, 201, 207 Product market freedom, 26, 58-61 Product market freedom matrix, 21,
59 (exhibit), 60, 70, 141,142 (exhibit), 143
Profitability, 5, 25, 31-32, 33, 37, 61, 63, 64,66, 87, 88, 99,126, 147,158, 160, 202,210
short-term focus on profits, 191 Protectionism, 6,123, 124, 201 Public opinion/public relations, 95,130, 134
Putonghua language, 6
Qingdao, 10,46, 90 Qing dynasty, 7 QQ company, 68 Qualcomm company, 82
Railways, 9, 46,48 (exhibit), 77 R&D. See Research and development Raw materials, 103, 201 Real estate sector, 12
Recession/economic crisis of 2008-2009, 5, 6, 11, 12,31,34, 73, 83,106,110, 117,123, 124, 130, 147,158, 170, 173,189, 197, 205, 209,218 aftermath of, 200-204 and decoupling notion, 208 Redefining Global Strategy (Ghemawat), 19
Reforms, 5, 18, 32, 36-37, 92, 93, 99,110, 204. See also Economic restructuring/liberalization; Industry: industrial restructuring/liberalization Regulatory change, 103,177,189-190, 220
Renminbi currency, 107, 122. See also Yuan currency
Ren Zhengfei, 55, 56-57, 78,160 Research and development (R&D), 57, 58,68, 75, 76, 77, 78, 82, 88,102, 120,121, 122, 138, 144,152, 168, 170,182,201
funding of research, 120, 200 Resource companies, 70,210 Retail sales, 28, 29 (exhibit), 48-49, 60, 80,177
Revenues of Chinese companies in Fortune's Global 500, 65 (exhibit) Rio Tinto company, 67, 70,127,130,133, 201,211
Royal Bank of Scotland (RBS), 106 Royal DSM company (Netherlands), 171-172
Rural development, 200, 204 Russia, 74,102
SAIC Motors, 180
Samsung company, 80,145,158, 213 Sanofi Aventis, 152 SASAC. See Assets Supervision and Administration Commission Schoemaker, Paul, 215 Science, 20, 74, 217 Services, 43,117,122